Authors:
BLAZSEK I
DELMASMARSELET B
LEGRAS S
MARION S
TAOUFIK Y
MACHOVER D
MISSET JL
Citation: I. Blazsek et al., ROLE OF MARROW STROMA IN ACUTE MYELOID-LEUKEMIA (AML) - SYSTEMIC LOSSOF HEMATON UNITS AND EMERGENCY OF A RARE, CELL-ADHESION-DEPENDENT LEUKEMIA-CELL LINE (1143-HULEX) IN LONG-TERM CULTURE, Experimental hematology, 26(8), 1998, pp. 73-73
Authors:
TAILLANDIER J
ALEMANNI M
CHARLES B
CHARPENTIER A
NDAW D
SZEKELY AM
MACHOVER D
Citation: J. Taillandier et al., SWEETS-SYNDROME AS THE FIRST MANIFESTATIO N OF ACUTE MYELOMONOCYTIC LEUKEMIA, La Semaine des hopitaux de Paris, 74(17-18), 1998, pp. 794-796
Authors:
BLAZSEK I
LEGRAS S
MARION S
PILLIER C
THIERY JP
MACHOVER D
MISSET JL
Citation: I. Blazsek et al., RECOVERY AND EXPANSION OF STROMA CELL-ASSOCIATED PRIMITIVE HEMATOPOIETIC PROGENITORS FROM FILTER RETAINED BONE-MARROW (BM), Experimental hematology, 25(8), 1997, pp. 61-61
Authors:
BLAZSEK I
LEGRAS S
MARION S
JASMIN C
THIERY JP
MACHOVER D
MISSET JL
Citation: I. Blazsek et al., ENDOTHALL, A WEAK PROTEIN(SER THR) PHOSPHATASE TYPE-2A (PP2A) INHIBITOR, SELECTIVELY KILLS ACUTE MYELOGENOUS LEUKEMIA-CELLS AT THE G2/M PHASE, BUT NOT NORMAL CD34(+) HEMATOPOIETIC PROGENITOR CELLS/, Experimental hematology, 25(8), 1997, pp. 84-84
Citation: D. Machover, A COMPREHENSIVE REVIEW OF 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, Cancer, 80(7), 1997, pp. 1179-1187
Authors:
MACHOVER D
DIAZRUBIO E
DEGRAMONT A
SCHILF A
GASTIABURU JJ
BRIENZA S
ITZHAKI M
METZGER G
NDAW D
VIGNOUD J
ABAD A
FRANCOIS E
GAMELIN E
MARTY M
SASTRE J
SEITZ JF
YCHOU M
Citation: D. Machover et al., 2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES, Annals of oncology, 7(1), 1996, pp. 95-98
Authors:
BLAZSEK I
FARABOS C
QUITTET P
LABAT ML
BRINGUIER AF
TRIANA BK
MACHOVER D
REYNES M
MISSET JL
Citation: I. Blazsek et al., BONE-MARROW STROMAL CELL DEFECTS AND 1-ALPHA,25-DIHYDROXYVITAMIN D-3 DEFICIENCY UNDERLYING HUMAN MYELOID LEUKEMIAS, Cancer detection and prevention, 20(1), 1996, pp. 31-42
Authors:
LEVI F
MACHOVER D
MARTY M
DIAZRUBIO E
DEGRAMONT A
GARUFI C
ITZHAKI M
CVITKOVIC E
BENSMAINE MA
BRIENZA S
MISSET JL
Citation: F. Levi et al., OXALIPLATIN (L-OHP(R)) - SUMMARY OF RESULTS IN ADVANCED COLORECTAL-CANCER (ACC), European journal of cancer, 31A, 1995, pp. 738-738
Authors:
BLAZSEK I
LEMONNIER MP
PILLIER C
LIU XH
MACHOVER D
MISSET JL
Citation: I. Blazsek et al., LARGE-SCALE PURIFICATION OF STROMAL CELLS AND HEMATOPOIETIC PROGENITOR CELLS FROM HUMAN HAEMATONS, Experimental hematology, 22(8), 1994, pp. 826-826
Citation: D. Machover, THE PHARMACOLOGICAL MODULATION OF 5-FLUOROURACIL WITH FOLINIC ACID, METHOTREXATE, TRIMETREXATE, AND N-PHOSPHONACETYL-1-ASPARTIC ACID (PALA)- MECHANISMS OF THE INTERACTIONS AND CLINICAL-DATA, Bulletin du cancer, 81, 1994, pp. 74-77
Authors:
MACHOVER D
GRISON X
GOLDSCHMIDT E
ZITTOUN J
METZGER G
RICHAUD J
LOTZ JP
ANDRE T
HANNOUN L
MARQUET J
GUILLOT T
BARDON M
SALMON R
SEZEUR A
MAUBAN S
IZRAEL V
PARC R
Citation: D. Machover et al., 5-FLUOROURACIL COMBINED WITH THE [6S]-STEREOISOMER OF FOLINIC ACID INHIGH-DOSES FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - A PHASE-I-II STUDY OF 2 CONSECUTIVE REGIMENS, Annals of oncology, 4, 1993, pp. 190000029-190000035